Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

The usual dose of Novo Nordisk’s expensive weight-loss drug Wegovy can be cut in half without affecting the results, researchers reported on Tuesday at the European Congress on Obesity in Malaga, ...

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.